These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8173702)

  • 1. The Nordic Diltiazem Study (NORDIL). A prospective intervention trial of calcium antagonist therapy in hypertension.
    Blood Press; 1993 Dec; 2(4):312-21. PubMed ID: 8173702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
    Kjeldsen SE; Hedner T; Syvertsen JO; Lund-Johansen P; Hansson L; Lanke J; Lindholm LH; De Faire U; Dahlöf B; Karlberg BE;
    J Hypertens; 2002 Jun; 20(6):1231-7. PubMed ID: 12023696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress report on the Nordic diltiazem study (NORDIL): an outcome study in hypertensive patients.
    Hedner T
    Blood Press; 1999; 8(5-6):296-9. PubMed ID: 10803490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
    Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE
    Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of home and office blood pressure in treated hypertensives in the Nordic Diltiazem (NORDIL) Study.
    Kjeldsen SE; Hedner T; Syvertsen JO; Lund-Johansen P; Hansson L;
    Blood Press; 2002; 11(6):371-6. PubMed ID: 12523681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The INSIGHT and NORDIL trials: Are calcium antagonists equivalent to established drug therapies for cardiovascular protection?
    Ruddy MC
    Curr Hypertens Rep; 2001 Aug; 3(4):289-96. PubMed ID: 11470011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    Achard JM; Oudart N; Aldigier JC
    Lancet; 2000 Dec; 356(9245):1926-7; author reply 1928-9. PubMed ID: 11130401
    [No Abstract]   [Full Text] [Related]  

  • 11. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
    Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L
    Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
    Hansson L; Lindholm LH; Niskanen L; Lanke J; Hedner T; Niklason A; Luomanmäki K; Dahlöf B; de Faire U; Mörlin C; Karlberg BE; Wester PO; Björck JE
    Lancet; 1999 Feb; 353(9153):611-6. PubMed ID: 10030325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What, if anything, is controversial about calcium antagonists?
    Messerli FH
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients.
    Svensson-Färbom P; Wahlstrand B; Almgren P; Dahlberg J; Fava C; Kjeldsen S; Hedner T; Melander O
    J Hypertens; 2011 Feb; 29(2):388-95. PubMed ID: 21052022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    Avanzini F; Tognoni G
    Lancet; 2000 Dec; 356(9245):1927-8; author reply 1928-9. PubMed ID: 11130404
    [No Abstract]   [Full Text] [Related]  

  • 16. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.
    Liu L; Zhang Y; Liu G; Li W; Zhang X; Zanchetti A;
    J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods.
    Fukui T; Rahman M; Hayashi K; Takeda K; Higaki J; Sato T; Fukushima M; Sakamoto J; Morita S; Ogihara T; Fukiyama K; Fujishima M; Saruta T;
    Hypertens Res; 2003 Dec; 26(12):979-90. PubMed ID: 14717341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    Fournier A; Georgita A; Bouffandeau B; Oprisiu R
    Lancet; 2000 Dec; 356(9245):1927; author reply 1928-9. PubMed ID: 11130405
    [No Abstract]   [Full Text] [Related]  

  • 19. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail.
    Brozena SC; Johnson MR; Ventura H; Hobbs R; Miller L; Olivari MT; Clemson B; Bourge R; Quigg R; Mills RM; Naftel D
    J Am Coll Cardiol; 1996 Jun; 27(7):1707-12. PubMed ID: 8636558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.